Accelerate Diagnostics Stock Price (NASDAQ:AXDX)

Add to My Stocks
$21.6 $0.75 (3.36%) AXDX stock closing price Jul 20, 2018 (Closing)
Prev Close* : $22.35
Market Cap:
$1.21B
Day Low: $21.5
52 Week Low: $16.75
Open: $22.35
Volume: -
Day High: $22.5
52 Week High: $30.35
Dividend:
0.00

Latest Stock Market News

Latest Articles

Accelerate Diagnostics News - From Partners

AXDX Stockcharts

View AXDX PE ratio, PS ratio stocks charts and compare with peers.
AXDX Chart
Note: Compare Accelerate Diagnostics stock price history with the index and industry peers.

Accelerate Diagnostics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
271.29
PB ratio (
price to book ratio
)
10.61

Accelerate Diagnostics Returns

ROE
(return on equity)
-61%

Accelerate Diagnostics Financial Ratios

Asset Turnover
0.02
Receivables Turnover
4.15
Debt to Equity
0.93
Dividend Yield
0%

AXDX Industry Peers

Company Price Change (%)
Luminex (LMNX)33.320.67 (1.97%)
Tandem Diabetes Care (TNDM)26.890.28 (1.05%)
Natus Medical (BABY)32.750.2 (0.61%)
Becton Dickinson (BDX)247.030.05 (0.02%)
Pacific Biosciences Of California (PACB)3.750.01 (0.27%)
Illumina (ILMN)311.152.05 (0.66%)
Fluidigm (FLDM)6.560.28 (4.46%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Fluidigm (FLDM)6.560.28 (4.46%)
APOLLO ENDOSURG (APEN)8.280.18 (2.22%)
IDEXX Laboratories (IDXX)248.145.32 (2.19%)
Edwards Lifesciences (EW)152.622.34 (1.56%)
Accuray (ARAY)40.05 (1.27%)
Tandem Diabetes Care (TNDM)26.890.28 (1.05%)
CryoLife (CRY)29.950.2 (0.67%)
Top gainers from Medical Instruments industry
* As of Jul 20, 2018
CompanyPriceChange (%)
Accelerate Diagnostics (AXDX)21.60.75 (3.36%)
K2M Group (KTWO)21.370.62 (2.82%)
Luminex (LMNX)33.320.67 (1.97%)
Inogen (INGN)209.723.77 (1.77%)
Opko Health (OPK)5.890.07 (1.17%)
Oxford Immunotec Global (OXFD)12.680.14 (1.09%)
RTI Surgical (RTIX)4.750.05 (1.04%)
Top losers from Medical Instruments industry
* As of Jul 20, 2018

Accelerate Diagnostics Inc Stock News - Partner Headlines

Accelerate Diagnostics Financial Statements

income statement20172016201520142013
Net Sales or Revenues4.17M----
Net Income-64.02M-66.37M-45.49M-30.93M-15.28M
Total Operating Expense67.35M66.74M45.69M30.74M14.98M
View Accelerate Diagnostics income statement
balance sheet20172016201520142013
Total Assets125.51M82.85M139.32M69.8M43.43M
Total Liabilities6.8M5.03M6.3M3.81M1.91M
Shareholders Equity118.7M77.81M133.01M65.99M41.51M
View Accelerate Diagnostics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-8.44M1.54M-1.36M1.25M
Net Cash from (used by) Operating Activities-55.74M-53.4M-35.12M-18.78M-9.74M
Increase (Decrease) in Prop Plant And Equipment-2.96M-2.4M-3.65M-1.93M-1.15M
View Accelerate Diagnostics cash flow statement

Accelerate Diagnostics Stock Message Board

An investor needs to spend $21.6 to buy AXDX stock, as the closing Accelerate Diagnostics stock price is $21.6. Accelerate Diagnostics market capitalization is $1.21B and it represents the total market value of AXDX stock. Accelerate Diagnostics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Accelerate Diagnostics stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Accelerate Diagnostics stock quote data shows the number of shares traded. For Ex: 171,366 Accelerate Diagnostics shares were traded as of last trading day, as seen from Accelerate Diagnostics stock chart. Accelerate Diagnostics paid 0.00 stock dividends to its shareholders during last quarter. Accelerate Diagnostics stock price history, gives the entire historical data for AXDX stock.